Susquehanna International Group’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-59,168
| Closed | -$286K | – | 5332 |
|
|
2020
Q1 | $286K | Buy |
59,168
+34,245
| +137% | +$166K | ﹤0.01% | 3473 |
|
|
2019
Q4 | $265K | Sell |
24,923
-33,869
| -58% | -$360K | ﹤0.01% | 3254 |
|
|
2019
Q3 | $612K | Buy |
58,792
+14,051
| +31% | +$146K | ﹤0.01% | 2635 |
|
|
2019
Q2 | $685K | Buy |
+44,741
| New | +$685K | ﹤0.01% | 2558 |
|
|
2019
Q1 | – | Sell |
-195,237
| Closed | -$1.86M | – | 5116 |
|
|
2018
Q4 | $1.86M | Buy |
195,237
+125,186
| +179% | +$1.19M | ﹤0.01% | 1006 |
|
|
2018
Q3 | $1.16M | Buy |
70,051
+25,286
| +56% | +$420K | ﹤0.01% | 1331 |
|
|
2018
Q2 | $718K | Buy |
+44,765
| New | +$718K | ﹤0.01% | 1895 |
|
|
2018
Q1 | – | Sell |
-36,579
| Closed | -$571K | – | 4992 |
|
|
2017
Q4 | $571K | Buy |
36,579
+10,665
| +41% | +$166K | ﹤0.01% | 2292 |
|
|
2017
Q3 | $288K | Buy |
+25,914
| New | +$288K | ﹤0.01% | 2523 |
|
|
2017
Q2 | – | Sell |
-75,746
| Closed | -$648K | – | 4735 |
|
|
2017
Q1 | $648K | Buy |
75,746
+6,824
| +10% | +$58.4K | ﹤0.01% | 2062 |
|
|
2016
Q4 | $737K | Buy |
+68,922
| New | +$737K | ﹤0.01% | 2581 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4333 |
|
|
2016
Q2 | – | Sell |
-44,988
| Closed | -$210K | – | 4429 |
|
|
2016
Q1 | $210K | Buy |
44,988
+33,685
| +298% | +$157K | ﹤0.01% | 3318 |
|
|
2015
Q4 | $71K | Sell |
11,303
-21,202
| -65% | -$133K | ﹤0.01% | 4018 |
|
|
2015
Q3 | $287K | Buy |
32,505
+19,072
| +142% | +$168K | ﹤0.01% | 3544 |
|
|
2015
Q2 | $158K | Buy |
13,433
+1,683
| +14% | +$19.8K | ﹤0.01% | 4156 |
|
|
2015
Q1 | $170K | Sell |
11,750
-578
| -5% | -$8.36K | ﹤0.01% | 3784 |
|
|
2014
Q4 | $210K | Sell |
12,328
-6,815
| -36% | -$116K | ﹤0.01% | 3990 |
|
|
2014
Q3 | $239K | Buy |
+19,143
| New | +$239K | ﹤0.01% | 3409 |
|
|
2014
Q1 | – | Sell |
-10,568
| Closed | -$207K | – | 4207 |
|
|
2013
Q4 | $207K | Buy |
+10,568
| New | +$207K | ﹤0.01% | 3511 |
|